Cargando…

Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

BACKGROUND: Insulin aspart (IAsp) and its biphasic preparations BIAsp50 and BIAsp70 (containing 50% and 70% IAsp, respectively) have distinct glucose-lowering properties as compared to human insulin (HI). We investigated whether this affected the circulating IGF-system which depends on the hepatic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhulin, Christiansen, Jens Sandahl, Laursen, Torben, Wu, Chunsen, Lauritzen, Torsten, Parkner, Tina, Frystyk, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986432/ https://www.ncbi.nlm.nih.gov/pubmed/24725803 http://dx.doi.org/10.1186/1472-6823-14-35

Ejemplares similares

The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
por: Stuard, Whitney L., et al.
Publicado: (2020)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
por: Lee, D. Y., et al.
Publicado: (1997)

Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
por: van Dijk, P R, et al.
Publicado: (2014)

IGF-I Bioactivity in an Elderly Population: Relation to Insulin Sensitivity, Insulin Levels, and the Metabolic Syndrome
por: Brugts, Michael P., et al.
Publicado: (2010)

Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers
por: Palmer, RM, et al.
Publicado: (2002)

Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers
por: Palmer, RM, et al.
Publicado: (2002)

Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
por: Alvino, Clair L., et al.
Publicado: (2011)

IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor
por: Versteyhe, Soetkin, et al.
Publicado: (2013)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Identification of insulin-like growth factor (IGF)-I and IGF-binding protein in chylous ascites.
por: Lee, D. Y.
Publicado: (1998)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Sensitization and translocation of TRPV1 by insulin and IGF-I
por: Van Buren, Jeremy J, et al.
Publicado: (2005)

The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
por: Malaguarnera, Roberta, et al.
Publicado: (2012)

The STC2–PAPP-A–IGFBP4–IGF1 axis and its associations to mortality and CVD in T2D
por: Gude, Mette Faurholdt, et al.
Publicado: (2023)

Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs
por: Song, Doo-Won, et al.
Publicado: (2021)

The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis
por: Hjortebjerg, Rikke, et al.
Publicado: (2019)

Investigating the Relationship Between IGF-I, IGF-II, and IGFBP-3 Concentrations and Later-Life Cognition and Brain Volume
por: Salzmann, Antoine, et al.
Publicado: (2021)

A Fasting Insulin–Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity
por: Mannino, Gaia Chiara, et al.
Publicado: (2013)

IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718
por: Andersen, Mie, et al.
Publicado: (2017)

Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1
por: Guan, Jian, et al.
Publicado: (2014)

Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
por: Lee, D. Y., et al.
Publicado: (1999)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

Correlation between Salivary Levels of IGF-1, IGFBP-3, IGF-1/IGFBP3 Ratio with Skeletal Maturity Using Hand-Wrist Radiographs
por: Almalki, Abdullah, et al.
Publicado: (2022)

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Publicado: (2010)

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
por: Watts, Eleanor L., et al.
Publicado: (2019)

Disrupting Insulin and IGF Receptor Function in Cancer
por: Cao, Jingran, et al.
Publicado: (2021)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020)

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
por: Oliva, Claudia R., et al.
Publicado: (2018)

Insulin-like Growth Factor 1 (IGF1), IGF Binding Protein-3 (IGFBP3) and Growth Response to Daily Zinc Supplementation: A Randomized Trial in Rural Laotian Children
por: Barffour, Maxwell A., et al.
Publicado: (2023)

Insulin‐like Growth Factor (IGF)‐I, IGF‐binding Protein‐3 and Colorectal Adenomas in Japanese Men
por: Teramukai, Satoshi, et al.
Publicado: (2002)

A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk
por: Allen, N E, et al.
Publicado: (2005)

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
por: Torrisi, R, et al.
Publicado: (2001)

Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling
por: Varewijck, Aimee J., et al.
Publicado: (2013)

Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell
por: Varma Shrivastav, Shailly, et al.
Publicado: (2020)

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin
por: Slaaby, Rita
Publicado: (2015)

Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours.
por: Reeve, J. G., et al.
Publicado: (1990)

The Association Between IGF-I and Insulin Resistance: A general population study in Danish adults
por: Friedrich, Nele, et al.
Publicado: (2012)

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
por: Varewijck, A. J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vehjssh0mn44bj3rt569pk6q2t